Logo
DCA

Becton, Dickinson and Company

sp500
BDXHealthcareMedical Instruments & Supplies
158,17 $US
-1.10%
Dernier cours
158,17 $US
2026-07-17
Variation 24h
-1.10%
-1.76 USD
Volume
1,7 M
Titres échangés
Fiabilité des données
Forte
13464 points (53 ans)

Évolution du cours

Lancer une simulation avec cet actif

BDX

Paramètres globaux

Données disponibles du 21/02/1973 au 17/07/2026

Analyse Fondamentale

New
CAGR (5y)
4.99%
Revenue Growth
Net Margin
7.68%
Profitability
ROE
6.61%
Return on Equity
Debt / EBITDA
3.87
Solvency
PEG Ratio
1.11
Valuation vs Growth
Rev. Growth (TTM)
5.20%
Current Trend

Historique PER (5 ans)

Historical PE
Average (39.5x)
Current: 27.6x
Focus technique
BDX
Volatilité 30j
26.05%
Écart MA50
6.20%
Écart MA200
-8.81%
Écart ATH
-44.23%
Momentum 3M
-0.23%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR8.27%
Volatilité26.05%
Max Drawdown-50.38%

Momentum : BDX

Indicateur synthétique
PEURNEUTREAVIDITÉ
51
Neutral

Analyse Risque

VaR (95%)-2.40%
Santé DCA
86/100

Historique récent (60 jours)

DateClôtureVolume
2026-07-17158,17 $US1 670 048
2026-07-16159,93 $US1 665 518
2026-07-15154,88 $US1 627 771
2026-07-14150,65 $US1 480 731
2026-07-13153,83 $US1 104 010
2026-07-10151,94 $US809 250
2026-07-09150,85 $US1 385 866
2026-07-08150,56 $US2 287 600
2026-07-07156,30 $US1 757 600
2026-07-06155,54 $US1 055 626
2026-07-02158,08 $US1 659 541
2026-07-01152,90 $US1 448 099
2026-06-30151,33 $US2 057 201
2026-06-29155,19 $US2 356 843
2026-06-26155,92 $US4 618 261
2026-06-25151,38 $US1 904 207
2026-06-24147,77 $US1 553 754
2026-06-23143,92 $US2 152 091
2026-06-22140,71 $US3 382 221
2026-06-18143,98 $US2 298 226
2026-06-17141,61 $US2 049 233
2026-06-16145,16 $US941 337
2026-06-15145,52 $US1 074 972
2026-06-12146,24 $US1 604 780
2026-06-11147,35 $US1 336 825
2026-06-10147,79 $US1 413 080
2026-06-09152,04 $US2 214 855
2026-06-08149,99 $US1 925 463
2026-06-05151,16 $US1 611 864
2026-06-04149,56 $US2 241 565
2026-06-03145,61 $US1 304 633
2026-06-02144,43 $US2 085 837
2026-06-01145,33 $US2 353 996
2026-05-29147,12 $US3 658 099
2026-05-28148,41 $US2 456 040
2026-05-27147,24 $US2 878 200
2026-05-26147,75 $US3 243 481
2026-05-22147,63 $US1 004 167
2026-05-21146,25 $US1 574 560
2026-05-20146,95 $US2 057 077
2026-05-19146,95 $US3 053 565
2026-05-18142,35 $US3 773 030
2026-05-15143,47 $US4 277 310
2026-05-14144,47 $US2 319 158
2026-05-13144,18 $US3 650 067
2026-05-12147,51 $US3 465 234
2026-05-11143,15 $US3 378 688
2026-05-08149,43 $US4 019 734
2026-05-07153,26 $US5 132 482
2026-05-06144,76 $US3 399 234
2026-05-05144,17 $US2 810 660
2026-05-04146,31 $US1 925 651
2026-05-01149,31 $US1 818 077
2026-04-30149,04 $US1 943 949
2026-04-29145,31 $US2 917 648
2026-04-28149,52 $US2 094 893
2026-04-27150,22 $US2 681 313
2026-04-24152,14 $US1 729 488
2026-04-23154,85 $US2 664 370
2026-04-22155,65 $US1 957 052

Derniers Dividendes

DateMontant
2026-03-10+1,05 $US
2025-12-08+1,05 $US
2025-09-08+1,04 $US
2025-06-09+1,04 $US
2025-03-10+1,04 $US
2024-12-09+1,04 $US
2024-09-09+0,95 $US
2024-06-10+0,95 $US
2024-03-07+0,95 $US
2023-12-07+0,95 $US
2023-09-07+0,91 $US
2023-06-08+0,91 $US
2023-03-09+0,91 $US
2022-12-08+0,91 $US
2022-09-08+0,87 $US
2022-06-08+0,87 $US
2022-03-09+0,85 $US
2021-12-09+0,85 $US
2021-09-08+0,81 $US
2021-06-08+0,81 $US

Actifs Relatifs